English
Spanish
Blog
Author Archives: lincolnreferencepost
UROVYSION for Bladder Cancer – (Fluorescence in-situ Hybridization (FISH))
Approved for NJ and NY UROVYSION – Urovysion™ is a sensitive and specific test used to diagnose urothelial carcinoma in urine. UroVysion has been approved by the FDA for both monitoring of patients with a history of bladder cancer and detection...
Read More ›
ONCOLOGY: Hematological Malignancies
Chronic Myeloid Leukemia (RT-PCR) – Currently approved only for NJ BCR-ABL assay is an in vitro nucleic acid amplification test for the quantitation of BCR-ABL1 and ABL1 transcripts in total RNA from whole blood of diagnosed t(9;22) positive...
Read More ›
HEREDITARY (GENETIC) SCREENING
Hemachromatosis (HFE Gene Testing) – Currently approved only for NJ HFE Hemochromatosis gene (HFE) testing is a blood test used to check for hereditary hemochromatosis, an inherited disorder that causes the body to absorb too much iron. The iron...
Read More ›
Fragile X (FXS Gene Testing)
Currently approved only for NJ Fragile X is a triplet CGG repeat primed PCR assay followed by fragment size analysis by capillary electrophoresis (CE). Methylation analysis is used to distinguish between premutation and full mutation alleles....
Read More ›
SMN1 testing (For Spinal Muscular Atrophy)
Currently approved only for NJ SMN1 is a multiplex PCR assay used to amplify exon 7 of the SMN1 gene along with an endogenous control gene followed by peak resolution by capillary electrophoresis. SMA is an autosomal recessive neuromuscular disease...
Read More ›
BRCA gene Screening (for Breast Cancer)
Currently approved only for NJ, submitted for NY approval Analysis of BRCA1 and BRCA2 genes is a crucial tool in breast and ovarian cancer screening. Lincoln Labs BRCA Analysis offers: Turnaround time of 10-15 days Preauthorization required....
Read More ›